Alaunos Therapeutics | ZIOP - Cash And Equivalent


Alaunos Therapeutics reported $354K in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Amgen USD 13.99B 1.95B Jun/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Baxter International USD 2.15B 133M Jun/2026
Biogen USD 1.28B 2.1B Jun/2026
Bioline Rx USD 2.5M 5.41M Mar/2026
Bristol-Myers Squibb USD 8.72B 852M Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Corcept Therapeutics USD 111.04M 2.3M Jun/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Curis USD 10.14M 10.14M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Gilead Sciences USD 7.63B 64M Mar/2026
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Incyte USD 3.98B 33.45M Jun/2026
Intrexon USD 9.34M 1.77M Jun/2024
Ionis Pharmaceuticals USD 350.06M 1.57B Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Karyopharm Therapeutics USD 90.85M 30.31M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Merck USD 6.85B 1.52B Jun/2026
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Novartis USD 7.62B 739M Jun/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pfizer USD 976M 727M Jun/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
PTC Therapeutics USD 1.05B 215.9M Jun/2026
Qiagen NV USD 646.29M 192.72M Mar/2026
Regeneron Pharmaceuticals USD 2.46B 506.8M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
TG Therapeutics USD 612.25M 170.04M Jun/2026
Tilray USD 264.83M 43.16M Jun/2025
Verastem USD 181.68M 23.31M Mar/2026
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026